Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Adenosine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 known ✓ | P0DMS8 | 1/20 | 0.54 |
| ▸ | ADORA2A known ✓ | P29274 | 1/20 | 0.54 |
| ▸ | ADORA2B known ✓ | P29275 | 1/20 | 0.54 |
| ▸ | ADORA1 known ✓ | P30542 | 1/20 | 0.54 |
| ▸ | DTYMK | P23919 | 4/20 | 0.69 |
| ▸ | F2 | P00734 | 1/20 | 0.57 |
| ▸ | DNMT1 | P26358 | 3/20 | 0.56 |
| ▸ | FPR2 | P25090 | 2/20 | 0.56 |
| ▸ | DNMT3B | Q9UBC3 | 2/20 | 0.56 |
| ▸ | RNASEL | Q05823 | 4/20 | 0.56 |
| ▸ | DPP4 | P27487 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.54 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.54 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.54 |
| ▸ | GAPDH | P04406 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | STAT6 | P42226 | 1/20 | 0.54 |
| ▸ | PI4KA | P42356 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine SCHEMBL531208 | 0.94 | DTYMK (0.76) | DTYMKDNMT1FPR2DNMT3BDPP4 | |
| Adenosine SCHEMBL6863617 | 0.94 | DTYMK (0.76) | DTYMKDNMT1FPR2DNMT3BDPP4 | |
| Adenosine SCHEMBL192733 | 0.91 | ADORA3 (0.63) | DTYMKDNMT1FPR2DNMT3BRNASEL | |
| Adenosine SCHEMBL23835231 | 0.91 | DTYMK (0.66) | DTYMKDNMT1FPR2DNMT3BDPP4 | |
| Adenosine SCHEMBL7101792 | 0.91 | DTYMK (0.66) | DTYMKF2DNMT1FPR2DNMT3B | |
| Guanosine SCHEMBL28215356 | 0.91 | F2 (0.60) | DTYMKF2DNMT1FPR2DNMT3B | |
| Adenosine SCHEMBL1549514 | 0.88 | DTYMK (0.66) | DTYMKDNMT1FPR2DNMT3BDPP4 | |
| Deoxyadenosine SCHEMBL20819422 | 0.87 | DTYMK (0.67) | DTYMKDNMT1FPR2DNMT3BSMN1; SMN2 | |
| Guanosine SCHEMBL11023852 | 0.87 | DTYMK (0.61) | DTYMKF2DNMT1FPR2DNMT3B | |
| Doxribtimine SCHEMBL787593 | 0.87 | SLC28A1 (0.65) | SLC28A1SLC28A2SMN1; SMN2SLC29A1SLC28A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5616566-A | CONTACTING THE HIV REVERSE TRANSCRIPTASE WITHIN THAT CELL WITH 2',3'-DIDEOXYADENOSINE-5'-TRIPHOSPHATE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-04-01 | — | — | US | disclosed |
| US-5254539-A | Method of treating HIV with 2',3'-dideoxyinosine | U.S. GOVERNMENT, DEPT. OF HEALTH AND HUMAN SERVICES, C/O NATIONAL INSTITUTES OF HEALTH (US) | 1993-10-19 | — | — | US | disclosed |
| US-4861759-A | Antiviral compositions and methods | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1989-08-29 | — | — | US | disclosed |